These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23153872)

  • 1. How to value technological innovation: a proposal for determining relative clinical value.
    Ladabaum U; Brill JV; Sonnenberg A; Shaheen NJ; Inadomi J; Wilcox CM; Park WG; Hur C; Pasricha PJ
    Gastroenterology; 2013 Jan; 144(1):5-8. PubMed ID: 23153872
    [No Abstract]   [Full Text] [Related]  

  • 2. Investor drought and regulatory headwinds slow device innovation.
    Russell S
    Health Aff (Millwood); 2015 Feb; 34(2):199-202. PubMed ID: 25646098
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiences of new product development in the medical device industry.
    Dixon D; Brown A; Meenan BJ; Eatock J
    Med Device Technol; 2006 Apr; 17(3):20-2. PubMed ID: 16736659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of clinical pathways in health care provision: Focus on cancer treatment.
    Kreys ED; Koeller JM
    Am J Health Syst Pharm; 2013 Jun; 70(12):1081-5. PubMed ID: 23719888
    [No Abstract]   [Full Text] [Related]  

  • 6. Medico-economic evaluation of healthcare products. Methodology for defining a significant impact on French health insurance costs and selection of benchmarks for interpreting results.
    Dervaux B; Baseilhac E; Fagon JY; ; Biot C; Blachier C; Braun E; Debroucker F; Detournay B; Ferretti C; Granger M; Jouan-Flahault C; Lussier MD; Meyer A; Muller S; Pigeon M; De Sahb R; Sannié T; Sapède C; Vray M
    Therapie; 2014; 69(4):323-8. PubMed ID: 25230355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursement pricing for new medical devices in Japan: Is the evaluation of innovation appropriate?
    Tamura M; Nakano S; Sugahara T
    Int J Health Plann Manage; 2019 Apr; 34(2):583-593. PubMed ID: 30549085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise of biomedical innovation.
    Weil AR
    Health Aff (Millwood); 2015 Feb; 34(2):198. PubMed ID: 25646097
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between anesthesia technology innovators, manufacturers, and purchasers.
    Gingles B
    Anesthesiol Clin; 2008 Dec; 26(4):785-92, viii. PubMed ID: 19041629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reimbursement of new medical technologies in German inpatient care: What factors explain which hospitals receive innovation payments?
    Ex P; Vogt V; Busse R; Henschke C
    Health Econ Policy Law; 2020 Jul; 15(3):355-369. PubMed ID: 31159902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key to Successful Budgeting? The Law of Large Numbers.
    Lynch PK
    Biomed Instrum Technol; 2017 Sept./Oct.; 51(5):437-439. PubMed ID: 28934576
    [No Abstract]   [Full Text] [Related]  

  • 12. Waking up to innovation: a tighter economic climate has the U.K.'s National Health Service looking for radical transformation.
    Anscombe N
    IEEE Pulse; 2014; 5(1):37-42. PubMed ID: 25296371
    [No Abstract]   [Full Text] [Related]  

  • 13. Is a paradigm shift in US healthcare reimbursement inevitable?
    Watanabe AM; Dollens RW; Malatestinic WN; Browne RA
    Circulation; 2004 Mar; 109(12):1456-9. PubMed ID: 15051649
    [No Abstract]   [Full Text] [Related]  

  • 14. Market watch: a framework for biomedical innovation in emerging markets.
    Gautam A; Yang S
    Nat Rev Drug Discov; 2014 Sep; 13(9):646-7. PubMed ID: 25176427
    [No Abstract]   [Full Text] [Related]  

  • 15. The need for greater price transparency in the medical device industry: an economic analysis.
    Hahn RW; Klovers KB; Singer HJ
    Health Aff (Millwood); 2008; 27(6):1554-9. PubMed ID: 18997211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Price controls for medical innovations in a life cycle perspective.
    Sorek G
    Health Econ; 2014 Jan; 23(1):108-16. PubMed ID: 23339083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical device technology user fees.
    Bailey PG
    Med Device Technol; 2002 Sep; 13(7):37-8. PubMed ID: 12397834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sending in-house HTMs to school for high-end equipment-is it worth it?
    Lynch PK
    Biomed Instrum Technol; 2014; 48(6):470-1. PubMed ID: 25408988
    [No Abstract]   [Full Text] [Related]  

  • 19. Price, value, and chaos theory in strategic management.
    Coss TA
    J Cardiovasc Manag; 1996; 7(4):21-4. PubMed ID: 10159788
    [No Abstract]   [Full Text] [Related]  

  • 20. Why oncologists need technology to succeed in alternative payment models.
    Fargnoli B; Holleran R; Kolodziej M
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP196-SP198. PubMed ID: 28665678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.